Promising treatment options of triple negative breast cancer
Date
2017
Journal Title
Journal ISSN
Volume Title
Publisher
Solen
Abstract
Description
Subject(s)
triple negative breast carcinoma, platinum derivates, olaparib, bevacizumab, eribulin, pembrolizumab
Citation
Item identifier
ISSN
1802-4475